| Previous close | 29.10 |
| Open | 29.10 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 920.00 |
| Expiry date | 2025-01-17 |
| Day's range | 29.10 - 29.10 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksHealth Care Stocks Show Relative Strength as S&P 500 Stalls
Several stocks are breaking out and trading near all-time highs.
Insider MonkeyIs Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) the Best Bet in Gene Therapy Industry?
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is the best bet in the gene therapy sector. Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a disease. This approach […]
ZacksFDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Per the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication constitutes a major amendment to its previously-submitted data. A final decision is expected by Sep 27.
© 2024 Yahoo. All rights reserved.